Serodus ASA Share Price

Stocks

03/17/03	Serodus : Primary endpoint reached by SER150 Phase 2a study in Diabetic Nephropathy.	PU
08/16/08	Serodus : Q&A delisting from Oslo Axess	PU
23/16/23	Serodus : Extraordinary general meeting held	PU
23/16/23	Serodus : Viggo Harboe Holding 2006 ApS announces results of voluntary offer	PU
02/16/02	Serodus : Viggo Harboe Holding 2006 Aps Launces voluntary offer for outstanding shares in Serodus ASA – Acceptance period starting 31 October 2016	PU

1 day

-5.56%

Manager	Title	Age	Since
Arnstein Gunnestad Endresen CEO	Chief Executive Officer	73	01/01/2023
Henrik Mordhorst DFI	Director of Finance/CFO	-	01/10/2019
Daniel Capion PRN	Corporate Officer/Principal	-	01/01/2021

Director	Title	Age	Since
Søren Elmann Ingerslev CHM	Chairman	-	01/01/2017
Terri Sebree BRD	Director/Board Member	68	01/04/2014
Viggo Gunnersen Harboe BRD	Director/Board Member	80	01/01/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SERODUS ASA	-5.56%	+7.94%	-	-	0
WUXI APPTEC CO., LTD.	-0.31%	+5.79%	+47.13%	+99.00%	7.09TCr
ARGENX SE	+0.39%	+2.06%	+39.38%	+78.27%	6.25TCr
WUXI BIOLOGICS (CAYMAN) INC.	+0.50%	+7.13%	+33.27%	+16.01%	2.63TCr
INSMED INCORPORATED	-3.21%	-7.27%	-17.10%	+356.10%	2.62TCr
BIONTECH SE	-2.64%	-0.69%	-0.17%	-13.01%	2.41TCr
GENMAB A/S	+0.71%	+8.03%	+25.03%	-12.74%	2.07TCr
PHARMAESSENTIA CORPORATION	+2.12%	-5.86%	+161.58%	+329.34%	1.54TCr
EXELIXIS, INC.	-0.22%	+3.99%	+45.54%	+172.46%	1.45TCr
SUMMIT THERAPEUTICS INC.	+0.73%	+1.71%	-5.51%	+849.47%	1.42TCr
Average	-0.75%	+1.74%	+36.57%	+208.32%	3.05TCr
Weighted average by Cap.	-0.28%	+1.49%	+35.68%	+148.22%

Employees

Sector